Crinetics Pharmaceuticals, Inc. Payments of Stock Issuance Costs
Crinetics Pharmaceuticals, Inc. (CRNX) reported Payments of Stock Issuance Costs of $578.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-03
- Crinetics Pharmaceuticals, Inc. payments of stock issuance costs for the quarter ending 2026-06-30 was $0.00.
- Crinetics Pharmaceuticals, Inc. payments of stock issuance costs for the quarter ending 2026-03-31 was $578.00K.
- Crinetics Pharmaceuticals, Inc. payments of stock issuance costs for the quarter ending 2025-12-31 was $0.00.
- Crinetics Pharmaceuticals, Inc. payments of stock issuance costs for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Crinetics Pharmaceuticals, Inc. payments of stock issuance costs for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Crinetics Pharmaceuticals, Inc. payments of stock issuance costs for fiscal 2024 was $14.98M, a 2669.32% increase from fiscal 2023.
- Crinetics Pharmaceuticals, Inc. payments of stock issuance costs for fiscal 2023 was $541.00K, a 93.03% decline from fiscal 2022.
- Crinetics Pharmaceuticals, Inc. payments of stock issuance costs for fiscal 2022 was $7.76M, a 40.16% decline from fiscal 2021.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 3 month as first filed | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 6 month as first filed | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 9 month as first filed | Payments of Stock Issuance Costs 12 month | Payments of Stock Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $578.00K 10-Q · filed 2026-08-03 | $578.00K derived: sum of 3 quarters · filed 2026-08-03 | $578.00K derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2026-03-31 | $578.00K 10-Q · filed 2026-05-07 | $578.00K derived: sum of 2 quarters · filed 2026-05-07 | $578.00K derived: sum of 3 quarters · filed 2026-05-07 | $578.00K derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-08-03 | $0.00 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-03 | $0.00 10-Q · filed 2025-11-06 | -$967.00K derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $0.00 10-Q · filed 2026-08-03 | -$967.00K derived: sum of 3 quarters · filed 2026-08-03 | -$814.00K derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | -$967.00K derived: sum of 2 quarters · filed 2026-05-07 | -$814.00K derived: sum of 3 quarters · filed 2026-05-07 | -$2.32M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$967.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$814.00K derived: sum of 2 quarters · filed 2026-02-26 | -$2.32M derived: sum of 3 quarters · filed 2026-02-26 | $14.98M 10-K · filed 2026-02-26 | $49.44M 10-K · filed 2025-02-27 | |||
| 2024-09-30 | $153.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.35M derived: sum of 2 quarters · filed 2025-11-06 | $15.95M 10-Q · filed 2025-11-06 | $17.30M 10-Q · filed 2024-11-12 | -$5.31M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | -$1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $15.80M 10-Q · filed 2024-08-08 | -$5.46M derived: sum of 3 quarters · filed 2026-02-26 | $15.99M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $17.30M 10-Q · filed 2025-05-08 | $15.81M 10-Q · filed 2024-05-09 | -$3.96M derived: sum of 2 quarters · filed 2026-02-26 | $17.49M derived: sum of 3 quarters · filed 2026-02-26 | $2.03M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | -$21.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $191.00K derived: sum of 2 quarters · filed 2026-02-26 | -$15.27M derived: sum of 3 quarters · filed 2026-02-26 | $541.00K 10-K · filed 2026-02-26 | $22.73M 10-K · filed 2024-02-28 | |||
| 2023-09-30 | $21.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $5.99M derived: sum of 2 quarters · filed 2024-11-12 | $21.80M 10-Q · filed 2024-11-12 | $21.76M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | -$15.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $350.00K 10-Q · filed 2024-08-08 | $300.00 10-Q · filed 2023-08-08 | $308.00K derived: sum of 3 quarters · filed 2025-02-27 | $8.10M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | $15.81M 10-Q · filed 2024-05-09 | $15.77M derived: sum of 2 quarters · filed 2025-02-27 | $23.56M derived: sum of 3 quarters · filed 2025-02-27 | |||||
| 2022-12-31 | -$42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $7.75M derived: sum of 2 quarters · filed 2025-02-27 | $7.76M 10-K · filed 2025-02-27 | $7.80M 10-K · filed 2023-02-28 | ||||
| 2022-09-30 | $7.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $7.80M 10-Q · filed 2023-11-07 | ||||||
| 2022-06-30 | $7.80K 10-Q · filed 2023-08-08 | |||||||
| 2021-12-31 | $12.96M 10-K · filed 2024-02-28 | $13.00M 10-K · filed 2022-03-30 | ||||||
| 2020-12-31 | $7.50M 10-K · filed 2023-02-28 | |||||||
| 2018-06-30 | $526.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $660.00K 10-Q · filed 2019-08-13 | ||||||
| 2018-03-31 | $134.00K 10-Q · filed 2019-05-13 |